Lipella Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights

Lipella Pharmaceuticals Inc share price today is $1.81, up -12.75%. The stock opened at $2.71 against the previous close of $2.705, with an intraday high of $2.91 and low of $2.25.

Lipella Pharmaceuticals Inc Share Price Chart

Lipella Pharmaceuticals Inc

us-stock
To Invest in {{usstockname}}
us-stock

Lipella Pharmaceuticals Inc Share Price Performance

$1.81 -0.1275(-12.75%) LIPO at 23 Mar 2026 01:59 PM Biotechnology
Lowest Today 2.25
Highest Today 2.91
Today’s Open 2.71
Prev. Close 2.705
52 Week High 7.75
52 Week Low 1.97
Day’s Range: Low 2.25 High 2.91
52-Week Range: Low 1.97 High 7.75
1 day return -
1 Week return -
1 month return -
3 month return -
6 month return -
1 year return -6.77
3 year return +2.63
5 year return -
10 year return -

Lipella Pharmaceuticals Inc Institutional Holdings

Fidelity Extended Market Index 0.13

Vanguard Institutional Extnd Mkt Idx Tr 0.10

Tower Research Capital LLC 0.06

Fidelity Series Total Market Index 0.03

Mccormack Advisors International 0.00

Bank of America Corp 0.00

Virtu Financial LLC 0.00

Lipella Pharmaceuticals Inc Market Status

Strong Buy: 0

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Lipella Pharmaceuticals Inc Fundamentals

Market Cap 12.82 M

PB Ratio 2.9625

PE Ratio 0.0

Enterprise Value 7.88 M

Total Assets 2.67 M

Volume 310975

Lipella Pharmaceuticals Inc Company Financials

Annual Revenue FY23:184156 0.2M, FY22:184156 0.2M, FY21:259347 0.3M, FY20:961683 1.0M

Annual Profit FY23:-2878583 -2.9M, FY22:-2363521 -2.4M, FY21:-1197444 -1.2M, FY20:-14277 -0.0M

Annual Net worth FY23:-4294006 -4.3M, FY22:-2596059 -2.6M, FY21:-1872203 -1.9M, FY20:-66450 -0.1M

Quarterly Revenue Q1/2025:129390000 129.4M, Q3/2024:80380 0.1M, Q2/2024:136431000 136.4M, Q1/2024:145880 0.1M, Q4/2023:120842 0.1M

Quarterly Profit Q1/2025:129390000 129.4M, Q3/2024:-966313 -1.0M, Q2/2024:135769442 135.8M, Q1/2024:145808 0.1M, Q4/2023:120119 0.1M

Quarterly Net worth Q1/2025:-1306523000 -1306.5M, Q3/2024:-1444637000 -1444.6M, Q2/2024:-938146000 -938.1M, Q1/2024:-1191809 -1.2M, Q4/2023:-688884 -0.7M

About Lipella Pharmaceuticals Inc & investment objective

Company Information Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrolimus to treat oral graft-versus-host disease; and LP-50, an intravesical formulation of immunoglobulins for the treatment of non-muscle invasive bladder cancer. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.

Organisation Biotechnology

Employees 5

Industry Biotechnology

CEO Dr. Jonathan Kaufman M.B.A., Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Lipella Pharmaceuticals Inc FAQs

What is the share price of Lipella Pharmaceuticals Inc today?

The current share price of Lipella Pharmaceuticals Inc is $1.81.

Can I buy Lipella Pharmaceuticals Inc shares in India?

Yes, Indian investors can buy Lipella Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Lipella Pharmaceuticals Inc shares in India?

You can easily invest in Lipella Pharmaceuticals Inc shares from India by:

Can I buy fractional shares of Lipella Pharmaceuticals Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Lipella Pharmaceuticals Inc?

Lipella Pharmaceuticals Inc has a market cap of $12.82 M.

In which sector does Lipella Pharmaceuticals Inc belong?

Lipella Pharmaceuticals Inc operates in the Biotechnology sector.

What documents are required to invest in Lipella Pharmaceuticals Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Lipella Pharmaceuticals Inc?

The PE ratio of Lipella Pharmaceuticals Inc is N/A and the PB ratio is 2.96.